Shamrock Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Shamrock Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$0	Hold	1	–	–	﹤0.01%	249
2019 Q2	$0	Hold	1	–	–	﹤0.01%	244
2019 Q1	$0	Hold	1	–	–	﹤0.01%	239
2018 Q4	$0	Buy	+1	New	+$148	﹤0.01%	242
2015 Q4	–	Sell	-50	Closed	-$7K	–	262
2015 Q3	$7K	Sell	50 -100	-67%	-$17.2K	﹤0.01%	217
2015 Q2	$26K	Sell	150 -50	-25%	-$8.98K	0.01%	181
2015 Q1	$35K	Hold	200	–	–	0.01%	155
2014 Q4	$33K	Hold	200	–	–	0.01%	126
2014 Q3	$32K	Hold	200	–	–	0.01%	168
2014 Q2	$29K	Hold	200	–	–	0.01%	198
2014 Q1	$28K	Buy	+200	New	+$30.1K	0.01%	191

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Shamrock Asset Management's JAZZ Position: Q3 2019 in Review

Shamrock Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2019 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Shamrock Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 11 quarters since. The position peaked at $35K in Q1 2015. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Shamrock Asset Management held 1 share of Jazz Pharmaceuticals worth $0 as of Q3 2019.
Shamrock Asset Management left its Jazz Pharmaceuticals share count unchanged in Q3 2019.
Jazz Pharmaceuticals made up ﹤0.01% of Shamrock Asset Management's portfolio in Q3 2019, its #249 holding.
Shamrock Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 11 quarters since.
Shamrock Asset Management's Jazz Pharmaceuticals position peaked at $35K in Q1 2015.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.